Most cancer patients who used medical cannabis reported a significant improvement in pain measures and a decrease in some other cancer-related symptoms. Additionally, medical cannabis use reduced the consumption of traditional, opioid-based pain killers for those with cancer.
Long-Term Effectiveness and Safety of Medical Cannabis Administered through the Metered-Dose SyqeAir Inhaler
Syqe®’s 2022 PAIN Reports study examined the long-term effectiveness and safety of medical cannabis treatment delivered via the metered-dose SyqeAir Inhaler under real-world conditions. Listen to the podcast.